CN115624613A - 强效修复细胞精华液 - Google Patents

强效修复细胞精华液 Download PDF

Info

Publication number
CN115624613A
CN115624613A CN202211323590.2A CN202211323590A CN115624613A CN 115624613 A CN115624613 A CN 115624613A CN 202211323590 A CN202211323590 A CN 202211323590A CN 115624613 A CN115624613 A CN 115624613A
Authority
CN
China
Prior art keywords
peptide
oyster
essence
cell
coral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211323590.2A
Other languages
English (en)
Inventor
张洪娥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202211323590.2A priority Critical patent/CN115624613A/zh
Publication of CN115624613A publication Critical patent/CN115624613A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/614—Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明公开了强效修复细胞精华液，涉及中医药领域，由珊瑚卵贝、牡蛎肽、葡萄籽、葵烯酸、蒲公英肽、天然矿物质钙和深海水及卵贝提取物组成。本发明无副作用，方便、易用，修复细胞迅速，有粉、水多用，可口服，可外用，从根本上调理，快速吸附病毒、细菌，所有疾病都是细胞出问题，这是一种高效、无副作用、纯天然精华液。

Description

强效修复细胞精华液
技术领域
本发明涉及中医药领域，具体为强效修复细胞精华液。
背景技术
现在患者为了减轻病痛的折磨，而无法负担高昂的手术费用，患者大多选择用口服药物来调理，长期用药使身体产生对药物的依赖性和抗药性，吃药不疼，不用药即疼，药物副作用大，身体慢慢拖垮，从而引发各种并发症，造成了吃一种药，变成了吃多种药，使身体形成了一体多病，无法摆脱“药罐”的被称。
发明内容
本发明的目的在于提供强效修复细胞精华液，以解决上述背景技术中提出的技术问题。
为实现上述目的，本发明提供如下技术方案：强效修复细胞精华液，是由以下重量份的原料药组成的：珊瑚卵贝3～5g、牡蛎肽3～5g、葡萄籽6～10g、葵烯酸6～10g、蒲公英肽8～12g、天然矿物质钙8～12g、深海水及卵贝提取物6～10g。
所述的强效修复细胞精华液，是由以下重量份的原料药组成的：珊瑚卵贝3g、牡蛎肽3g、葡萄籽6g、葵烯酸6g、蒲公英肽8g、天然矿物质钙8g、深海水及卵贝提取物6g。
上面所述强效修复细胞精华液的剂型为液剂。
本发明提供强效修复细胞精华液，无副作用，方便、易用，修复细胞迅速，有粉、水多用，可口服，可外用，从根本上调理，快速吸附病毒、细菌，所有疾病都是细胞出问题，这是一种高效、无副作用、纯天然精华液。
具体实施方式
临床典型病例：
病例1：崔某，男，67岁，①肺左叶占位并门脉癌栓，②肝硬化，脾大门静脉海绵样病变，食管胃底静脉曲张，腹水，③直肠癌。从喝本产品，无腹水，脾大好转，黄疸退去，精神佳，肿瘤明显减少，病情稳定。(当时医院已发病后)
病例2：李某，男，59岁，鳞状细胞癌，脑栓，咳嗽，咳白痰，不能手术，不能靶向。来此调理，口服产品后，不咳嗽，不咳痰，纵隔多发淋巴结转移，肿瘤明显减小，手脚活动自如，病情稳定。
病例3：战某，男，61岁，吐血，半身不遂，检查：右肺炎症，右侧胸腔积液、肝多发转移，十二指肠溃疡性肿物，不能手术。来此调理，口服产品，再无出血，十二指肠明显修复，肝部修复明显，所有血液检查合格，继续调理中。
下面结合具体实施例对本发明进一步地解释和说明：
实施例1强效修复细胞精华液
配方为：珊瑚卵贝3g、牡蛎肽3g、葡萄籽6g、葵烯酸6g、蒲公英肽8g、天然矿物质钙8g、深海水及卵贝提取物6g。
使用方法：口服或者外用涂抹。
实施例2强效修复细胞精华液
配方为：珊瑚卵贝5g、牡蛎肽5g、葡萄籽10g、葵烯酸10g、蒲公英肽12g、天然矿物质钙12g、深海水及卵贝提取物10g。
使用方法：口服或者外用涂抹。
实施例3强效修复细胞精华液
配方为：珊瑚卵贝4g、牡蛎肽8g、葡萄籽8g、葵烯酸8g、蒲公英肽10g、天然矿物质钙10g、深海水及卵贝提取物8g。
使用方法：口服或者外用涂抹。
实施例4强效修复细胞精华液
配方为：珊瑚卵贝3g、牡蛎肽3g、葡萄籽6g、葵烯酸6g、蒲公英肽9g、天然矿物质钙12g、深海水及卵贝提取物9g。
使用方法：口服或者外用涂抹。

Claims (3)

1.强效修复细胞精华液，其特征在于：是由以下重量份的原料药组成的：珊瑚卵贝3～5g、牡蛎肽3～5g、葡萄籽6～10g、葵烯酸6～10g、蒲公英肽8～12g、天然矿物质钙8～12g、深海水及卵贝提取物6～10g。
2.根据权利要求1所述的强效修复细胞精华液，其特征在于：是由以下重量份的原料药组成的：珊瑚卵贝3g、牡蛎肽3g、葡萄籽6g、葵烯酸6g、蒲公英肽8g、天然矿物质钙8g、深海水及卵贝提取物6g。
3.根据权利要求1或2所述的强效修复细胞精华液，其特征在于：所述强效修复细胞精华液的剂型为液剂。
CN202211323590.2A 2022-10-18 2022-10-18 强效修复细胞精华液 Pending CN115624613A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211323590.2A CN115624613A (zh) 2022-10-18 2022-10-18 强效修复细胞精华液

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211323590.2A CN115624613A (zh) 2022-10-18 2022-10-18 强效修复细胞精华液

Publications (1)

Publication Number Publication Date
CN115624613A true CN115624613A (zh) 2023-01-20

Family

ID=84906691

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211323590.2A Pending CN115624613A (zh) 2022-10-18 2022-10-18 强效修复细胞精华液

Country Status (1)

Country Link
CN (1) CN115624613A (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160028986A (ko) * 2014-09-04 2016-03-14 경상대학교산학협력단 간질환 예방 및 치료 효과가 있는 굴 유래 펩타이드
CN113975370A (zh) * 2021-12-10 2022-01-28 张洪娥 一种激活自身自愈力的药物
CN114848576A (zh) * 2022-06-15 2022-08-05 广州沙艾生物科技有限公司 一种细胞抗衰老精华液及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160028986A (ko) * 2014-09-04 2016-03-14 경상대학교산학협력단 간질환 예방 및 치료 효과가 있는 굴 유래 펩타이드
CN113975370A (zh) * 2021-12-10 2022-01-28 张洪娥 一种激活自身自愈力的药物
CN114848576A (zh) * 2022-06-15 2022-08-05 广州沙艾生物科技有限公司 一种细胞抗衰老精华液及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周田田 等: "牡蛎肽的提取纯化及生物活性研究进展", 食品科技, vol. 46, no. 7, 13 August 2021 (2021-08-13), pages 150 - 154 *

Similar Documents

Publication Publication Date Title
Li et al. Luteolin alleviates inflammation and modulates gut microbiota in ulcerative colitis rats
CN102166284B (zh) 一种治疗反流性食管炎的药物及其制备方法
CN115624613A (zh) 强效修复细胞精华液
CN101485872A (zh) 一种治疗胃病的中药组合物及其制备和质量控制方法
CN105560478A (zh) 一种治疗慢性溃疡性结肠炎的中药组合物
CN111920908B (zh) 一种治疗消化性溃疡的药物组合物
CN103446169A (zh) 一种三七皂苷r1的新用途
CN107913391B (zh) 一种用于治疗非糜烂性胃食管反流病的药物组合物及其制备方法和应用
CN104969906B (zh) 一种龟鳖用孵化材料及其制备方法
CN109718317B (zh) 一种治疗溃疡性结肠炎的中药组合物
CN103800466B (zh) 一种治疗口腔及消化道炎症或/和溃疡的马甲子提取物及制剂和应用
Lewis et al. Primary squamous-cell carcinoma of the cecum: report of a case
CN104127846A (zh) 一种治疗脚气的软膏及其制作方法
CN103393800B (zh) 一种治疗脾胃湿热型反流性食管炎的中药
CN102920801B (zh) 一种治疗胃病的中药制剂
CN115025138B (zh) 大血藤提取物在制备预防治疗溃疡性结肠炎药物中的应用
CN112168835B (zh) 一种毛里求斯排草素在制备利胆药物中的应用
CN107485684A (zh) 一种可快速治疗口腔溃疡的中药组合物及制备方法
CN102784206B (zh) 逆萎康及其制备方法
EP4199949A1 (en) Method for treating inflammatory bowel diseases
CN106511729A (zh) 一种新的乌鸡白凤丸
CN116531471A (zh) 一种用于治疗病毒感染湿热袭肺证的中药合剂
Risk Assessing and Improving Nutritional
Liu et al. Gastrointestinal Medicine
CN103877189A (zh) 一种治疗肝胃湿热型慢性胃炎的中药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination